• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MapLight Therapeutics, Inc. - Common Stock (NQ:MPLT)

9.360 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 493
Open 9.360
Bid (Size) 9.080 (300)
Ask (Size) 9.450 (100)
Prev. Close 9.360
Today's Range 9.360 - 9.360
52wk Range 8.920 - 40.43
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
October 06, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
MapLight Therapeutics to Participate in Upcoming Investor Conference
September 09, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 76.8% below 52-week high
9.360
8.9252W Low 40.4352W High
1 Week 8.0% below 1-week high
8.921W Low 10.171W High

MapLight Therapeutics, Inc. - Common Stock (MPLT) traded between $8.92 and $40.43 over the past 52 weeks and last traded at $9.36, 76.8% below its 52-week high. Over the past week it ranged between $8.92 and $10.17.

Past 12 Months
-2.8%
-32.9%
-75.7%
-61.4%
-44.2%
-49.0%
1W -$0.27
1M -$4.59
3M -$29.17
6M -$14.88
YTD -$7.41
1Y -$8.98

MPLT was -49.0% over the past year, -61.4% over six months, -44.2% year to date, -2.8% in the last week.

12 Months vs Market
MPLT
-49.0%
DIA
+9.7%
SPY
+16.2%
QQQ
+25.3%
IWM
+13.7%

Over the past 12 months MPLT returned -49.0% versus DIA (Dow) +9.7%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +25.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.00× 3-mo avg
Today 493 3-mo avg 851.3K
1W
406.2K
1M
487.4K
3M
851.3K
6M
614.9K
YTD
474.5K
1Y
459.3K

MPLT most recently traded 493 shares against a 3-month average daily volume of 851.3K.

More News

Read More
News headline image
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
MapLight Therapeutics Announces $150 Million Private Placement Financing
August 13, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-07-29: top gainers and losers in today's session. ↗
July 29, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
July 29, 2026
Via Chartmill
Which stocks are moving on Monday? ↗
July 27, 2026
Via Chartmill
News headline image
Maplight Therapeutics’ Schizophrenia Drug Hits Phase II Primary Endpoint ↗
July 27, 2026
Via MarketBeat
Monday's session: top gainers and losers ↗
July 27, 2026
Via Chartmill
News headline image
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law
July 27, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
July 27, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
July 27, 2026
Via Chartmill
News headline image
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
July 27, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
MapLight Therapeutics Announces Changes to Board of Directors
June 24, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
June 22, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles ↗
June 08, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million ↗
May 31, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge ↗
May 30, 2026
Via The Motley Fool
News headline image
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean ↗
May 30, 2026
Via The Motley Fool
News headline image
MapLight's CFO Just Sold 36,000 Shares for $1 Million. Is It a Buy, Sell, or Hold? ↗
May 15, 2026
Via The Motley Fool
Topics Derivatives Regulatory Compliance
News headline image
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
MapLight Therapeutics to Participate in Upcoming Investor Conferences
May 08, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of April ↗
May 04, 2026
Via The Motley Fool
Topics Derivatives Regulatory Compliance
News headline image
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
May 01, 2026
From MapLight Therapeutics, Inc.
Via GlobeNewswire
News headline image
What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data ↗
April 22, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is MapLight Therapeutics, Inc. - Common Stock publicly traded?
Yes, MapLight Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does MapLight Therapeutics, Inc. - Common Stock trade on?
MapLight Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MapLight Therapeutics, Inc. - Common Stock?
The ticker symbol for MapLight Therapeutics, Inc. - Common Stock is MPLT on the Nasdaq Stock Market
What is the current price of MapLight Therapeutics, Inc. - Common Stock?
The current price of MapLight Therapeutics, Inc. - Common Stock is 9.360
When was MapLight Therapeutics, Inc. - Common Stock last traded?
The last trade of MapLight Therapeutics, Inc. - Common Stock was at 10/07/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap